In 2012, Chicago’s Children’s Memorial Hospital will be in transition, with a change of name as well as location, when its top class technology, physicians, scientists, staff and patients transfer to a new state-of-the-art complex three miles away.
‘As we become more successful in the early detection and treatment of breast cancer, we tend to trivialise it. Yet one in 9 women still get breast cancer. Half of them become depressed, their partners don’t know how to react and their families are in disarray. We need to stop trivialising breast cancer. It kills women.’ So says Dr Fabienne Liebens, Head of the Saint-Pierre Hospital’s…
Prenatal ultrasound images are the first images we see of new humans. But the prenatal ultrasound first carried out by Professor Ian Donald in the late 50s has little to do with today’s potential with 3-D and 4-D imaging with Doppler and colour Doppler. The three tightly linked disciplines gynaecology, prenatal medicine and obstetrics would now be inconceivable without ultrasound
Catastrophes draw people closer, as demonstrated by the development of the new high-end ultrasound scanner Aplio 500 from Toshiba. The clinical evaluation period took place during the tsunami and the nuclear catastrophe in Fukusima. Professor Thomas Fischer at the Radiological Institute, Charité Clinic in Berlin, was impressed by the enormous commitment shown by the Japanese firm’s engineers…
The birth, in France, of its first baby to be conceived by artificial insemination on top of the selection of an embryo based on its blood, has sent new flames into the hot parliamentary debate over the reform of bioethics law.
As one of the first in Europe, the FUS Centre at the Klinikum Dachau in Germany introduced MRgFUS in 2008 as a gentle alternative for the treatment of fibroids. The success that has since been achieved in this encouraged Dr Matthias Matzko, head of radiology and of the FUS Centre, to take on a leading role with the introduction to the market of the second product generation, the ExAblate One.…
Philips Electronics and Atom Medical Corporation, a major manufacturer of neonatal medical equipment, announced today that they are expanding their relationship to serve customers with a more complete portfolio of perinatal care solutions.
Ultrasound is the undisputed choice for foetal imaging. However, the lack of amniotic fluid, an unfavourable foetal position or maternal obesity could daunt even the best radiographer. In such circumstances prenatal magnetic resonance imaging (MRI) – a non-invasive and non-irradiating procedure – is a helpful diagnostic tool.
Current cervical cancer screening is time consuming and expensive, but now new breakthrough technology developed by European researchers should allow large-range screening by non-medical personnel with almost immediate results and at a much lower cost.
Data from the ATHENA (Addressing THE Need for Advanced HPV Diagnostics) USA registration trial, involving more than 47,000 women, demonstrate that two human papilloma virus genotypes, HPV 16 and HPV 18, can identify those women with cervical pre-cancer missed by cytologic examination with a Papanicolau (Pap) test.
A probe suitable for imaging soft tissue for use with the VivoSight Multi-Beam optical coherence tomography (OCT) imaging system has been launched by manufacturer Michelson Diagnostics. The probe enables in vivo imaging of oral and gynaecological tissue.
The latest analysis of a vaccine’s safety, efficacy and immunogenicity indicates that Cervarix, a human papilloma virus (HPV) vaccine offers sustained protection for over six years against infection by viral types HPV-16 and HPV-18, most commonly associated with cervical cancer.
Breast and cervical cancer together account for more than one quarter of all female cancer deaths worldwide, with the majority – including more than 85 % of all cervical cancer deaths – occurring in developing countries. However, a small number of highly effective programs demonstrate that much can be done to reduce risk and increase sustainable access to diagnosis and treatment for these…
A study presented at the annual meeting of the Radiological Society of North America (RSNA) revealed that MRI is a highly accurate means of identifying placenta accreta, a potentially life-threatening and increasingly common condition that is the leading cause of death for women just before and after giving birth.
The United Kingdom has a strong medical devices industry; more than 2,000 companies employ over 50,000 people and support the employment of many more in this field. About 200 of these medical manufacturers are at Medica this year, at various pavilions, including those representing Wales, Scotland and Northern Ireland. Among the UK exhibitors, Zilico Ltd is presenting, for the first time, a…
Sonoace, the German distributor of the Korean firm Medison Co. Ltd has launched its first hand carried ultrasound machine MySono U5 at Medica. ‘Complete with various image optimisation processing technologies in a lightweight and compact form , Mysono U5 is designed to guarantee immediate diagnostics in a wide range of applications, such as emergency medicine, vascular, musculoskeletal and…
The new Isolette 8000 is the latest model in Dräger’s respected Isolette series of infant incubators that introduced innovations such as the patented Dual Air Curtain, known from the Isolette C2000. ‘This thermal management capability, which is also part of the Isolette 8000, reduces radiant heat loss from the infant and contributes to a cocoon-like environment, where the neonate can…
A global vaccination programme against human papilloma virus (HPV), to include boys as well as girls, could lead to eradication of the virus and virtual disappearance of cervical cancer, according to Nobel Prize winner, Professor Emeritus Harald zur Hausen (University of California, San Diego) after recently delivering a keynote lecture at the 16th International Meeting of the European Society of…
ECCO 15 – ESMO 34, the joint congress of the European CanCer Organisation (ECCO) and the European Society for Medical Oncology (ESMO), is Europe’s largest oncology meeting; the event drew to Berlin 15,000 participants from 120 countries this September, when more than 2,000 presentations were made. Among the presentations on prevention, treatment and survivorship, proteomics, biomarkers,…
Sonoace, the German distributor for Medison Co. Ltd, has announced the launch of a new, dedicated high performance OB/GYN ultrasound system, the ACCUVIX V20 ‘Prestige’, which features the industry's first multi-rendering 3-D/4-D technology, 3-D MXI (3-D Multi-eXtended Imaging ).
Designed for multi-applications (e.g. general imaging, obstetrics/gynaecology, abdomen, small parts, musculoskeletal, urology, vascular) MyLab 20Plus, manufactured by Esaote Biomedica Deutschland GmbH, can be customised to suit individual needs in a shared ultrasound department or clinic.
A global vaccination programme against human papilloma virus (HPV), to include boys as well as girls, could lead to eradication of the virus and virtual disappearance of cervical cancer, predicted Nobel Prize winner, Professor Harald zur Hausen, after delivering the key-note lecture at the 16th International Meeting of the European Society of Gynaecological Oncology (ESGO) in Belgrade, Serbia,…
In 2006, 4.3 million children were born in US hospitals; of these, 158,000 mothers and infants (3.5%) sustained injuries that could have been avoided. For comparison purposes, newly published US statistics could prove interesting for European hospital administrators, says Dot M McSherry of i.t. Communications
The fact that child diabetics (type I) in Russia do not receive necessary and qualitative therapy was again highlighted during the 7th Russian conference 'The priority national project - Health - and the tasks of children's endocrinologists' held in Saint-Petersburg this June.
Completion of a Phase I clinical trial has demonstrated the great promise of a completely new type of cancer treatment, according to results announced this June in The New England Journal of Medicine by scientists at the Institute of Cancer Research (ICR) and the Royal Marsden Hospital in the United Kingdom, working with pharma firm AstraZeneca.
